Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Die Aktien des Computerprozessoren-Herstellers Intel (NASDAQ: INTC) stiegen um 5,9% in der Nachmittags-Sitzung an, nachdem das Bank of America-Doppel-Upgrade weiter verarbeitet wurde. Analyst Vivek Arya erhöhte die Prognose für den Server-CPU-Markt auf mehr als 170 Milliarden US-Dollar bis 2030 und modellierte Intels Gewinnmachtigkeit auf mehr als 6 Dollar pro Aktie, im Gegensatz zu einem vorherigen Bereich von 3-4 Dollar. CEO Lip-Bu Tan sagte bei der Q1 FY2026-Konferenz, dass die CPU-GPU-Mischung sich von etwa 1:8 in trainingslastigen Bereichen auf etwa 1:4 verkürzt hat und möglicherweise sogar zu Parität oder noch weiter zu den CPUs tendieren könnte. BofA schätzt das externe Fertigungspotenzial bei über 45 Milliarden US-Dollar bis 2030 ein.

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Regulators, lawmakers, and consumer groups are fighting over what it means to be a community bank. The debate has implications for lenders and borrowers everywhere.

Continue Reading

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Key Points

Stock splits have enjoyed a resurgence in recent years. Historically, stock split stocks tend to beat the broader market. CrowdStrike has an excellent track record of growth and the backing of Wall Street's collective wisdom.10 stocks we like better than CrowdStrike ›

There's been a resurgence in the popularity of stock splits in recent years, driven by rising corporate profits and surging stock prices. It was common practice in the late 1990s, but fell out of fashion before enjoying a renaissance. This is historically a sign of a company performing at a high level, as evidenced by years, or even decades, of strong operating and financial results, which have driven the stock price out of reach for everyday investors.

Historically, these top-performing stocks continue to outpace their peers. History shows that companies that conduct stock splits generate stock price increases of 25%, on average, in the year following the announcement, compared with average gains of 12% for the S&P 500, according to data compiled by BofA analyst Jared Woodard.

Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »

Let's look at one recent stock split that still has plenty of upside ahead, according to Wall Street.

Image source: Getty Images.

AI in its DNA

Artificial intelligence (AI) has been all the rage in recent years, but CrowdStrike Holdings(NASDAQ: CRWD) has built a cybersecurity empire that leveraged AI before it was fashionable. The company's Falcon platform offers the most sophisticated threat protection available, infused with its Charlotte AI, which was designed for the world of generative and agentic AI.

The need for its services has never been greater. The global average cost of a data breach last year was $4.44 million, according to a report by IBM, and the threat worsens with every passing year. The abilities of AI to find exploits take that problem to the next level.

CrowdStrike has long been a trailblazer in the cybersecurity industry. It was recognized as a Leader in Gartner's 2026 Magic Quadrant for Endpoint Protection for the seventh consecutive year. Perhaps as importantly, the company was chosen as a Leader in Gartner's inaugural 2026 Magic Quadrant for Cyberthreat Intelligence Technologies, cited for its "completeness of vision" and "ability to execute."

The company's results are compelling. For its fiscal 2027 first quarter (ended April 30), CrowdStrike reported revenue that climbed 26% year over year to $1.39 billion, driven higher by record annual recurring revenue (ARR) that grew 24% to $5.5 billion. This drove adjusted earnings per share (EPS) up 51% to $1.10.

Wall Street is bullish about CrowdStrike's future. Of the 54 analysts who offered an opinion in June, 78% rate it a buy or strong buy. Furthermore, Wall Street's average price target on the stock is about $712, implying additional upside of 10% compared to Wednesday's closing price.

However, one analyst is much more bullish. Rosenblatt Securities analyst Catharine Trebnick has a price target of $825 -- the highest among her Wall Street peers -- suggesting CrowdStrike stock could climb as much as 27% from its current price (as of market close on Wednesday). The analyst called CrowdStrike's Q1 financial report "outstanding." She goes on to say that the "intersection of frontier AI models and cybersecurity has positioned the Falcon platform as critical AI infrastructure."

Her thinking is on point. When AI start-up Anthropic unveiled its Claude Mythos Preview, the frontier AI model revealed "thousands of high-severity vulnerabilities, including some in every major operating system and web browser" that hackers could use to gain access to critical systems. Anthropic formed a coalition to address these exploits, and CrowdStrike was one of just two cybersecurity companies invited to participate.

CrowdStrike's valuation is enough to make value investors cringe, so it likely won't be a fit for everyone. The stock is currently selling for 111 times forward earnings -- which is pricey to be sure. However, CrowdStrike has soared 362% over the past three years, more than five times the 71% return of the S&P 500, which underlines why it's worthy of a premium valuation.

Should you buy stock in CrowdStrike right now?

Before you buy stock in CrowdStrike, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and CrowdStrike wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $442,220! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,230,114!

Now, it’s worth noting Stock Advisor’s total average return is 926% — a market-crushing outperformance compared to 203% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of June 12, 2026.

Bank of America is an advertising partner of Motley Fool Money. Danny Vena, CPA has positions in CrowdStrike. The Motley Fool has positions in and recommends CrowdStrike and International Business Machines. The Motley Fool recommends Gartner. The Motley Fool has a disclosure policy.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

(Bloomberg) -- Global banks are curbing hedge funds' leveraged bets on Asia's top chipmakers including SK Hynix Inc. and Samsung Electronics Co. after a blistering rally this year raised concerns of a potential pullback, according to people familiar with the matter.

Most Read from Bloomberg

SpaceX IPO Raises $75 Billion in Biggest Debut of All Time Xbox Plans Significant Layoffs as New CEO Plans Overhaul Trump Insists Iran Deal Is Close After Scrapping New Strikes Trump Vows New Attacks on Iran, Threatens Key Energy Targets UAE and Iran Meet Face-to-Face to Try to Deescalate Tensions

Brokers including Citigroup Inc., JPMorgan Chase & Co. and Goldman Sachs Group Inc. have raised the financing cost for hedge funds to take bullish wagers on SK Hynix and Samsung Electronics shares via swaps, said the people.

Banks have also tightened the size of new trades and which firms they will give them to, the people said, asking not to be identified while discussing private information. They have taken similar steps for Taiwan Semiconductor Manufacturing Co., the people added.

Morgan Stanley is turning away clients seeking new swap trades in the two Korean stocks while some second-tier banks have also stopped accepting additional orders in the past two weeks, the people said. Some large global banks that are still willing to take new orders are assessing requests on a case-by-case basis, they added.

The moves came after a wild run in the two companies' shares this year, part of a global boom in tech stocks that is fueling fears of a bubble. The stock price of SK Hynix has more than tripled this year, while Samsung Electronics is up over 175%. These moves have helped Korea's benchmark Kospi Index jump around 100%, making it the best performing market in the world.

But the chipmakers' shares have recently come under pressure: Both SK Hynix and Samsung Electronics tumbled on Wednesday, as the tech rally faltered. At least some of the curbs started before the recent selloff, the people said.

Bank of America Corp., BNP Paribas and UBS Group AG are also lifting financing costs and restricting the size of swap trades in the two stocks, the people said.

Shares of SK Hynix and Samsung pared gains on the news. The Kospi index also gave back some of its earlier gains.

Swaps are a popular way for hedge funds to bet on assets without actually owning them and with the aid of leverage. In markets like South Korea, where few hedge funds have their own trading IDs with the exchange, swaps with brokers are the default way to bet on stocks.

Story Continues

Swap financing rates quoted by the banks on SK Hynix and Samsung Electronics were increased to a range from 300 basis points to as much as 11% over the secured overnight financing rate (SOFR), the people added. With SOFR standing at 3.6%, the new rates translate into nearly 15% at the top end of the range.

That compares with financing rates between around 100 and 200 basis points above SOFR in early May, the people said. The new rates apply to new swap contracts or those being rolled over, they added.

While banks writing swaps often find other counterparties to take the other side of hedge fund clients' trades, few firms are willing to make bearish bets on the gravity-defying gains of SK Hynix and Samsung Electronics. That means banks sometimes have to deploy their own balance sheets, putting a constraint on how much business they're willing to take.

Banks are concerned that a major correction would affect the value of their clients' holdings, leading to potential defaults on margin calls and ultimately threatening losses for banks, the people said.

While one benefit of swap trades has traditionally been the built-in leverage, some banks are now insisting clients pay up in full for those positions, said the people.

Mega-IPOs including SpaceX's $75 billion listing this week are also expected to tie up bank balance sheets, giving them more incentive to control the amount of capital they deploy to trades in SK Hynix and Samsung Electronics, the people said.

Citigroup, Goldman Sachs, JPMorgan, Morgan Stanley and UBS declined to comment. Bank of America and BNP Paribas didn't immediately respond to requests for comment.

AI Frenzy

Hedge funds have shown huge interest in South Korea over the past year, after regulators lifted a short selling ban and pushed through corporate governance reforms. But much of the focus has been on the chipmakers, which are seen as key beneficiaries of the global AI race.

SK Hynix and Samsung Electronics between them now represent around 53% of Korea's benchmark Kospi Index. That is more than double their combined weight five years ago, before the frenzy around AI transformed global markets.

The insatiable demand for these stocks has in part been fueled by exchange-traded funds. Roundhill Investments's actively managed Memory ETF has seen assets surge to $16.7 billion after its inception in early April. SK Hynix and Samsung Electronics account for more than 40% of its holdings as of Thursday, according to information posted on the website of the New York-based company.

CSOP Asset Management Ltd.'s eight-month-old, Hong Kong-listed ETF seeking to replicate twice the daily performance of SK Hynix shares surpassed $10.9 billion in assets at the start of this month, according to data compiled by Bloomberg.

Financing rates quoted by banks for swap trades involving the same stocks vary wildly from bank to bank, and from client to client. They can depend on what sort of other assets — and how much — a hedge fund holds at the time, the strength of its relationship with brokers and the banks' ability to facilitate more trades.

The Kospi tumbled nearly 9% intraday on Monday, triggering a 20-minute trading halt by the exchange as investors pulled back from AI trades. SK Hynix's shares are down this month, while the CSOP fund's assets have declined.

(Update adds market reaction in the eighth paragraph, Morgan Stanley no comment in paragraph 16.)

Most Read from Bloomberg Businessweek

Gen Z's Latest Career Flex: A Boardroom Seat Ice Cream Not Decadent Enough for You? Dip It in Butter SpaceX IPO Demands Trust in Musk's Entangled Empire How a Tiny British Island Fell Into an International Gambling Scandal El Niño Slams Into a Global Economy Unprepared for More Chaos

©2026 Bloomberg L.P.

View Comments

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Regulators, lawmakers, and consumer groups are fighting over what it means to be a community bank. The debate has implications for lenders and borrowers everywhere.

Continue Reading

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

(Bloomberg) -- Bayer AG shares are facing a make-or-break few weeks, with two upcoming court developments key to stemming a more than $60 billion wipeout in market value since the German company’s ill-fated purchase of Monsanto eight years ago.

Most Read from Bloomberg

SpaceX IPO Raises $75 Billion in Biggest Debut of All Time Xbox Plans Significant Layoffs as New CEO Plans Overhaul Trump Insists Iran Deal Is Close After Scrapping New Strikes Trump Vows New Attacks on Iran, Threatens Key Energy Targets UAE and Iran Meet Face-to-Face to Try to Deescalate Tensions

Investors are awaiting a US Supreme Court ruling on Bayer’s bid to stop tens of thousands of lawsuits claiming that Monsanto’s Roundup herbicide should have been labeled as a cancer risk. Around the same time, a fairness hearing over a separate $7.25 billion class-action settlement to resolve current and future cancer lawsuits over Roundup is also scheduled.

If most of the litigation is resolved, the stock would become more investable and could rise to €50, according to Jefferies analyst Michael Leuchten. In a downside scenario, with another double-digit billion-euro litigation provision and a multi-decade overhang, the shares could fall to €30, he wrote. Bayer closed at €35.79 on Thursday.

“The litigation overshadows everything,” said Markus Manns, portfolio manager at Frankfurt-based asset manager Union Investment, a Bayer investor. “Only once there is clarity on the litigation can the company develop a reliable financial plan regarding earnings growth, debt reduction and other priorities.”

A Bayer spokesperson said Monsanto has “a multipronged strategy” and is “confident but prepared” for all outcomes with regard to both the Supreme Court case and the class settlement agreement.

The Supreme Court is expected to rule by early July. Justices heard arguments in April, weighing a $1.25 million jury verdict won by a Missouri man who blamed Roundup for his non-Hodgkin lymphoma. Bayer contends that since US regulators didn’t require a cancer warning, federal law bars the Missouri suit and others like it.

A favorable outcome in the Supreme Court will help to ease Bayer’s legal issues because it would wipe out failure-to-warn theories that have provided the basis for big-dollar verdicts in Roundup cases. The April hearing was less positive for Bayer than some had expected, and the shares have been trending lower since then.

Listen: Bayer’s Cancer Claims Roundup at US Supreme Court: BI Podcast

Still, analysts at Bank of America Corp. recently cited a legal expert who sees a 70% probability that the court rules in Bayer’s favor. And Barclays Plc analyst Charles Pitman-King expects the company “to make significant progress in resolving the majority of its outstanding litigation overhang,” helping it to unlock its fundamental valuation.

Story Continues

Settlement Hearing

The other key milestone is over Bayer’s $7.25 billion proposal to settle thousands of current and future Roundup claims. A fairness hearing is scheduled for July 9 in state court in Missouri, but opponents of the settlement have asked for a transfer to San Francisco to get the case in front of a federal judge who has already publicly noted the deal’s flaws. Bayer objected the move and said it’s confident it has good arguments for the case to be returned to Missouri’s courts.

Potential changes to the location and, therefore, timing of that decision have also unsettled investors, who are keen to move on from the Monsanto saga.

Bayer investor Manns thinks the company is likely to get its way in at least one of the cases. “I expect that a majority, likely more than 80%, of plaintiffs will support the proposal, as the settlement terms are very favorable,” he said.

“However, if both efforts fail, then we would be looking at a significant, possibly catastrophic, setback for Bayer. The long-term financial uncertainty would remain. Investors would never know when the next €5 billion settlement payment might be required.”

Bayer has already paid more than $11 billion in Roundup settlements and still faces more than 65,000 current suits blaming its active ingredient, glyphosate, for causing non-Hodgkin lymphoma, according to securities filings. The shares are down more than 60% since the company completed the $63 billion Monsanto deal.

“Bayer’s hubristic purchase of Monsanto, with what must be viewed as woeful due diligence, has been the ultimate corporate nightmare that keeps on giving,” said Ketan Patel, a fund manager at the family office Whitefriars, which doesn’t own Bayer shares.

Patel sees risks to Bayer around both rulings, noting that a Supreme Court decision against the company “could open the floodgates in every State where Roundup was sold, and where the rules surrounding labeling are interpreted differently from State to State.”

Many are more positive on the company’s prospects. The shares have 16 buy ratings among 21 analysts tracked by Bloomberg, with an average price target that suggests more than 40% upside. For Barclays’ Pitman-King, who rates Bayer overweight, the resolution of litigation could also open the door to a possible consumer health separation in future, helping the stock achieve its estimated €53 to €60 sum-of-the-parts valuation.

Still, even if the two upcoming cases go Bayer’s way, the company has other legal battles to contend with. While Monsanto stopped supplying toxic chemicals known as polychlorinated biphenyls — or PCBs — to customers for use in their products decades ago, the company has been sued by state and local governments, school districts and individuals.

Bayer has already agreed to pay almost $2 billion in settlements in PCB cases, and potentially faces billions of dollars in exposure from a growing number of lawsuits over PCB products filed by state and local governments, school districts and individuals. It is pursuing a strategy to recoup some of its litigation costs from other companies, such as General Electric Co., that were large users of the chemicals.

Read: Bayer Faces Billions in Payouts for Decades-Old Toxic Mess

“The lesson of the last decade I’d draw is: there’s always someone in the US who wants to sue Monsanto,” said Berenberg’s Sebastian Bray. “A Supreme Court victory would be a great way of protecting Bayer, but it probably wouldn’t solve absolutely everything.”

--With assistance from Jef Feeley.

Most Read from Bloomberg Businessweek

Gen Z’s Latest Career Flex: A Boardroom Seat How a Tiny British Island Fell Into an International Gambling Scandal The Bankrupting of a Mobile Home Billionaire Ice Cream Not Decadent Enough for You? Dip It in Butter SpaceX IPO Demands Trust in Musk’s Entangled Empire

©2026 Bloomberg L.P.

View Comments

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Der Aktienkurs von Intel (INTC) stieg um 5,1% in der Morgen-Sitzung nach einer seltene Doppel-Upgrade durch Bank of America. BofA bewertete Intel auf "Kaufen" und erhöhte das Zielpreis auf $135 von $96. Analyst Vivek Arya zitierte zwei Treiber: stärkerer Server-CPU-Demande verbunden mit agenter AI-Arbeit, sowie verbesserte Sichtbarkeit für die Intel-Foundry nach berichtetem Google/Alphabet-Plan, Intel mehr als drei Millionen TPUs in 2028 herstellen zu lassen. Industrieberichte zitieren auch Intels EMIB fortgeschrittene Verpackung (mit Ausbeutungen von etwa 90% bei der Validierung) als potenzielles Alternativprodukt, wobei die Ausbeutefigur aus Handel/Analysten-Kanälen stammt und nicht im Upgrade-Text von BofA enthalten ist.

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Intel Corp (NASDAQ:INTC, XETRA:INL) scored a double upgrade to Buy from Underperform by Bank of America, which raised its price objective to $135 from $96 on higher confidence in the chipmaker's ability to capitalize on growing opportunities in central processing units and contract manufacturing.

Analysts now project Intel's total calendar year 2030 earnings per share power at more than $6, up from a prior estimate of $3 to $4, driven by expectations that agentic CPU sales could surpass $40 billion and external foundry revenue could exceed $45 billion by 2030.

Shares of Intel were up over 5% on Thursday.

Bank of America now expects Intel's server CPU sales to reach more than $40 billion by 2030, representing roughly 25% share of what it sizes as a $170 billion-plus total addressable market. For its foundry business, the bank flagged potential engagements including Apple M-Series wafers, MediaTek TPU wafers, Terafab IP and packaging, ARM-based server CPUs, and edge AI expansion into client computing.

Analysts also pointed to Intel's recent Cadence "14A node" IP sign-up and Terafab engagements as supportive data points that help build longer-term foundry visibility and a more sustainable IP ecosystem.

The bank flagged Intel's ownership profile as a potential catalyst for further stock gains.

Despite a market capitalization of approximately $540 billion, Intel remains the second-least owned semiconductor and AI infrastructure stock in the S&P 500, with just 16% institutional ownership as of May 2026.

Bank of America drew a comparison to AMD, where ownership rose roughly 1,400 basis points year-over-year to 39% in May, a period during which AMD shares gained more than 300%.

Key risks to the outlook include intensifying competition from ARM-based and custom chip designs, potential moderation in AI capital expenditure affecting CPU demand, and execution risk in both leading-edge design and foundry operations.

View Comments

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Quick Read

BRK-B generated $46 billion in operating cash flow in 2025 and trades at just 15x earnings, making it a rare cheap compounder. With a beta of 0.62 and debt-to-equity of 0.19, Berkshire's fortress balance sheet lets it buy aggressively when panicked markets force others to sell. Greg Abel inherits a decentralized, owner-aligned culture that delivered 244% returns over a decade with far less volatility than the S&P 500. Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Berkshire Hathaway didn't make the cut. Grab the names FREE today.

If you are building a portfolio you intend to never touch again, Berkshire Hathaway (NYSE:BRK-B) warrants a central role, because it is engineered to compound capital across decades regardless of who is in the White House, what the Federal Reserve is doing, or which sector is in fashion.24/7 Wall St.

Pillar One: A Business Built to Outlast Cycles

Berkshire operates more like a privately run economy than a single stock. It wholly owns GEICO, Duracell, Dairy Queen, BNSF, Lubrizol, Fruit of the Loom, Helzberg Diamonds, Long & Foster, FlightSafety International, Pampered Chef, Forest River, and NetJets, alongside meaningful stakes in Kraft Heinz (26.7%), American Express (18.8%), Coca-Cola (9.32%), Bank of America (11.9%), and Apple (6.3%). The structural bias is exactly what a retirement investor wants: cyclical, cash-rich businesses like insurance (GEICO), railroads (BNSF), and utilities that are mathematically primed to benefit from the simple reality that the U.S. and global economies spend significantly more time expanding than contracting. The BEA data confirms it: across the last 20 quarters, only two showed negative GDP growth.

Pillar Two: Compounding Without a Dividend Check

Berkshire pays no dividend, and that is by design. Instead of mailing income out, management reinvests every dollar at high rates of return and runs a premier capital return program through buybacks. Operating cash flow has held in a tight band for a decade, from $30.6 billion in 2024 to $49.2 billion in 2023, with $45.97 billion generated in 2025 and $10.4 billion in Q1 2026 alone. Recent annual equity repurchases include $9.17 billion in 2023 and $27.06 billion in 2021, with a 1,220,376-share repurchase on May 1, 2026. Every buyback quietly increases your ownership of the entire conglomerate.

Pillar Three: Designed to Survive What Kills Other Stocks

The balance sheet is the moat under the moat. Debt-to-equity sits at 0.19, interest coverage at 11.6 times, and beta at 0.617, meaning the stock moves less than the market by design. Even in the 2022 mark-to-market storm that produced a $22.06 billion net loss, operating cash generation stayed at $37.2 billion. Insurance float gives Berkshire low-cost capital precisely when capital is most expensive elsewhere, which is why it buys when others are forced to sell.

Story Continues

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Berkshire Hathaway didn't make the cut. Grab the names FREE today.

When It Lags, and Why That Is Fine

Berkshire will underperform during speculative bull markets driven by narrow technology rallies. Over the past year, BRK-B is down 1.13% while the S&P 500 ETF returned 22.91%. Over a decade, the gap is much smaller: BRK-B has returned 244.08% against the S&P 500 ETF's 250.86%, with materially less drawdown risk along the way. The conservatism that causes the lag is the same conservatism that allows the company to be standing, and buying, when the cycle turns. Succession is in place: Greg Abel is the successor to Warren Buffett, and the operating culture he inherits is decentralized, owner-aligned, and unchanged.

With a trailing P/E of 15 and diluted EPS of $33.58, the valuation is rational. For long-horizon investors, the structure favors patient ownership.

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Berkshire Hathaway didn't make the cut. Grab the names FREE today.

View Comments

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Citigroup is IBD's Stock Of The Day as it makes a blockchain move while executing on a massive turnaround that has sharply boosted profitability. On Thursday, the Wall Street Journal confirmed earlier reports about Citigroup rolling out tokenized shares of private companies for its wealthy and institutional clients. Basically, that means Citi will use a blockchain-based platform to convert equity in pre-IPO private companies into digital tokens.

Continue Reading